Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2489361 Title: Verwendung von zellpermeablen peptid-inhibitoren des JNK-signal-transduktionspfads zur behandlung verschiedener erkrankungen

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
120006630
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2489361
WO publication number:
1rst applicant's nationality:
Translation language:
German
EPO publication language:
English
SPC number:

Dates

Filing date:
02/06/2009
Grant date:
16/04/2014
EP publication date:
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
27/06/2014
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
16/04/2014
EP B1 publication date:
16/04/2014
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/06/2024
Expiration date (if granted and all annual fees paid):
02/06/2029

Applicant

Name:
Xigen Inflammation Ltd.
Legal Form:
From:
16/04/2014
Address:
Arch. Makariou III 195 Neocleous House, 3030 Limassol, Cyprus (CY)
To:

Agent

Name:
LAMBERT Romain
Legal Form:
From:
27/06/2014
Address:
Route d'Arlon 234 P.O. Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
Bonny, Christophe
Legal Form:
Address:

Priority

Priority patent number:
PCT/EP2008/0
Priority date:
30/05/2008
Priority country:
World Intellectual Property Office (WIPO) (WO)

Classification

Main IPC class:
A61K 38/01;
IPC or IDT classification:
A61K 38/03; A61K 38/04; A61P 9/00; A61P 11/00; A61P 17/00; A61P 25/00; A61P 31/12; A61P 37/00;

Publication

Bulletin

Bulletin heading:
EP3
Journal edition number:
2014/06
Publication date:
16/09/2019
Description:
Contains data concerning European patents granted for Belgium and published (B1 publication) in English and for which a translation in Dutch, French or German was filed under the Belgian Patent Laws

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
20/06/2023
Last annual fee paid number:
15
Last annual fee paid amount:
360 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
27/06/2014 General Document (TP - T:Traduction Originale plus Pouvoir) 187 PDF /1/6/3/9/8/0512489361/migrated-docs/120006630_1_327187.pdf